Search research articles
Contact Us
Filters
Showing results (51-60 of 159) with videos related to
Page
of 16
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2006
PET/CT imaging in response evaluation of patients with small cell lung cancer
Barbara M Fischer, Jann Mortensen, Seppo W Langer, et al.
Nuclear Medicine and Biology
|
March 1, 2016
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma
Mette Kjoelhede Nedergaard, Signe Regner Michaelsen, Lara Perryman, et al.
Neuro-Oncology
|
April 22, 2010
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen, et al.
Cancer Investigation
|
February 8, 2019
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
Maria Dinche Johansen, Thomas Urup, Camilla Bjørnbak Holst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 2, 2008
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
Morten Sorensen, Ulrik Lassen, Peter Buhl Jensen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 17, 2005
Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomised clinical trial
Soeren S Larsen, Peter Vilmann, Mark Krasnik, et al.
Anti-Cancer Drugs
|
December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment
Carla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.
JCO Precision Oncology
|
June 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis
Ulrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
Hossein Borghaei, Katherine Alpaugh, Gunnar Hedlund, et al.
Neuro-Oncology Advances
|
December 11, 2024
Magnetic resonance imaging and o-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma
Otto Mølby Henriksen, Simone Maarup, Benedikte Hasselbalch, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 159) with videos related to
Sort By:
Page
of 16
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2006
PET/CT imaging in response evaluation of patients with small cell lung cancer
Barbara M Fischer, Jann Mortensen, Seppo W Langer, et al.
Nuclear Medicine and Biology
|
March 1, 2016
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma
Mette Kjoelhede Nedergaard, Signe Regner Michaelsen, Lara Perryman, et al.
Neuro-Oncology
|
April 22, 2010
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen, et al.
Cancer Investigation
|
February 8, 2019
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
Maria Dinche Johansen, Thomas Urup, Camilla Bjørnbak Holst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 2, 2008
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
Morten Sorensen, Ulrik Lassen, Peter Buhl Jensen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 17, 2005
Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomised clinical trial
Soeren S Larsen, Peter Vilmann, Mark Krasnik, et al.
Anti-Cancer Drugs
|
December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment
Carla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.
JCO Precision Oncology
|
June 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis
Ulrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2009
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
Hossein Borghaei, Katherine Alpaugh, Gunnar Hedlund, et al.
Neuro-Oncology Advances
|
December 11, 2024
Magnetic resonance imaging and o-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma
Otto Mølby Henriksen, Simone Maarup, Benedikte Hasselbalch, et al.
Page
of 16